India to United States: Ipratropium Export Trade Route
India has recorded 341 verified shipments of Ipratropium exported to United States, representing a combined trade value of $14.8M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $43.4K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 85% of total export value with 197 shipments worth $12.5M USD. On the buying side, CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest importer in United States with $12.3M USD in purchases. The top 3 suppliers — CIPLA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, RUBICON RESEARCH LIMITED — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Ipratropium corridor is one of India's established pharmaceutical export routes, with 341 shipments documented worth a combined $14.8M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 85% of all export value, reflecting the consolidated nature of India's ipratropium manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $43.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with ipratropium's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 27.5%, placing it at rank #12 among India's top ipratropium export destinations globally.
On the import side, key buyers of Indian ipratropium in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES INC and 7 others. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the single largest importer with 184 shipments valued at $12.3M USD.
Route Characteristics
- Average transit22 days
- Peak seasonQ3
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#12
- Annual growth+27.5%
- Demand growth+25.0%
- Regulatory ease82/100
Top 10 Indian Ipratropium Exporters to United States
Showing top 10 of 7 Indian suppliers exporting Ipratropium to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $63.7K per shipment | 197 | $12.5M | 84.8% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $15.5K per shipment | 109 | $1.7M | 11.4% |
| 3 | RUBICON RESEARCH LIMITED Avg $13.9K per shipment | 21 | $292.3K | 2.0% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $26.1K per shipment | 10 | $260.6K | 1.8% |
| 5 | TULSI MEDICAL & GENERAL STORES Avg $82 per shipment | 2 | $165 | 0.0% |
| 6 | VEA IMPEX (I) PRIVATE LIMITED Avg $64 per shipment | 1 | $64 | 0.0% |
| 7 | GLENMARK PHARMACEUTICALS LIMITED Avg $12 per shipment | 1 | $12 | 0.0% |
This table shows the top 10 of 7 Indian companies exporting ipratropium to United States, ranked by total trade value. The listed exporters are: CIPLA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, RUBICON RESEARCH LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, TULSI MEDICAL & GENERAL STORES, VEA IMPEX (I) PRIVATE LIMITED, GLENMARK PHARMACEUTICALS LIMITED. CIPLA LIMITED is the dominant supplier with 197 shipments worth $12.5M USD, giving it a 85% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Top 10 Ipratropium Importers in United States
Showing top 10 of 10 known buyers in United States receiving Ipratropium shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ipratropium in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES INC, CIPLA USA INC UPS SUPPLY CHAIN SOL, EVERSANA LIFE SCIENCES SERVICES LLC, among 10 total buyers. The largest importer is CIPLA USA INC UPS SUPPLY CHAIN SOLU, accounting for $12.3M USD across 184 shipments — representing 83% of all ipratropium imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | 184 | $12.3M | 83.1% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES,INC. | 70 | $1.1M | 7.7% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES INC | 49 | $812.6K | 5.5% |
| 4 | CIPLA USA INC UPS SUPPLY CHAIN SOL | 13 | $258.0K | 1.7% |
| 5 | EVERSANA LIFE SCIENCES SERVICES LLC | 12 | $230.5K | 1.6% |
| 6 | EVERSANA LIFE SCIENCE SERVICES LLC | 9 | $61.8K | 0.4% |
| 7 | CONSIGNEE MASTER & OWNER OF CHLOE D | 1 | $133 | 0.0% |
| 8 | TO THE ORDER OF INVOICE RAISED TO | 1 | $64 | 0.0% |
| 9 | Consignee Master & Owner Of UOG HER | 1 | $32 | 0.0% |
| 10 | GLENMARK PHARMACEUTICALS INC USA | 1 | $12 | 0.0% |
Top 10 Ipratropium Formulations Imported by United States
Showing top 10 of 134 product formulations shipped on the India to United States Ipratropium route, ranked by trade value
United States imports a wide range of ipratropium formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE INHALATION SOLUTION 0.5MG & 3MG/3ML NDC NO. 6909717364 ANDA NO. 077559 (12 — accounts for $4.6M USD across 3 shipments. There are 134 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE INHALATION SOLUTION 0.5MG & 3MG/3ML NDC NO. 6909717364 ANDA NO. 077559 (12 | 3 | $4.6M | 30.8% |
| 2 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE INHALATION SOLUTION 0.5MG & 3MG/3ML; [PAC SIZE:12X5X3MLX8484 PAC=509040 NOS] | 1 | $1.5M | 10.1% |
| 3 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE INHALATION SOLUTION 0.5MG & 3MG/3ML; NDC NO. 6909717353; ANDA NO. :#077559 PAC | 7 | $1.3M | 8.6% |
| 4 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE INHALATION SOLUTION 0.5MG & 3MG/3ML; [PAC SIZE:6X5X3MLX17136 PAC=514080 NOS] | 1 | $786.5K | 5.3% |
| 5 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFAT | 22 | $711.8K | 4.8% |
| 6 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE INHALATION SOLUTION 0.5MG&3MG/3MLNDC NO.6909717353 ANDA NO:#077559PACK SIZE6X5 | 1 | $634.5K | 4.3% |
| 7 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE INHALATION SOLUTION 0.5MG & 3MG/3ML;NDC [PAC/S:6X5X3 MLX12480 PAC=374400 NOS] | 1 | $522.9K | 3.5% |
| 8 | IPRATROPIUM BROMIDE & ALBUTEROL SULFATE | 15 | $417.2K | 2.8% |
| 9 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE INHALATION SOLUTION 0.5MG & 3MG/3ML; NDC NO. 6909717364; ANDA NO. : #077559 PA | 1 | $336.3K | 2.3% |
| 10 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFAT | 8 | $243.5K | 1.6% |
Showing top 10 of 134 Ipratropium formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 139 shipments. Transit time averages 22 days by sea.
Market Dynamics
India's ipratropium exports to United States are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 197 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, RUBICON RESEARCH LIMITED — together account for 98% of total trade value on this route. The average shipment value of $43.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as ipratropium bromide and albuterol sulfate inhalation solution 0.5mg & 3mg/3ml; [pac size:12x5x3mlx8484 pac=509040 nos] and ipratropium bromide and albuterol sulfate inhalation solution 0.5mg & 3mg/3ml; ndc no. 6909717353; anda no. :#077559 pac, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest importer with 184 shipments worth $12.3M USD — representing 83% of all ipratropium imports from India on this route. A total of 10 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $14.8M
- Avg. Shipment
- $43.4K
- Suppliers
- 7
- Buyers
- 10
- Transit (Sea)
- ~22 days
- Annual Growth
- +27.5%
Related Analysis
Other Ipratropium Routes
Unlock the Full India to United States Ipratropium Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 341 shipments on this route.
Frequently Asked Questions — India to United States Ipratropium Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ipratropium to United States?
The leading Indian exporters of Ipratropium to United States are CIPLA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, RUBICON RESEARCH LIMITED. CIPLA LIMITED holds the largest market share at approximately 85% of total trade value on this route.
Q What is the total value of Ipratropium exports from India to United States?
India exports Ipratropium to United States worth approximately $14.8M USD across 341 recorded shipments. The average value per shipment is $43.4K USD.
Q Which ports does India use to ship Ipratropium to United States?
The most active port of origin is SAHAR AIR with 139 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 25% by air.
Q How long does shipping take from India to United States for Ipratropium?
The average transit time for Ipratropium shipments from India to United States is approximately 22 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Ipratropium trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.5% with demand growth tracking at 25.0%. The route is ranked #12 among India's top Ipratropium export destinations globally.
Q How many suppliers are active on the India to United States Ipratropium route?
There are currently 7 active Indian suppliers exporting Ipratropium to United States. The market is moderately concentrated with CIPLA LIMITED accounting for 85% of total shipment value.
Q Who are the main importers of Ipratropium from India in United States?
The leading importers of Indian Ipratropium in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES INC, CIPLA USA INC UPS SUPPLY CHAIN SOL, EVERSANA LIFE SCIENCES SERVICES LLC. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest buyer with 184 shipments worth $12.3M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Ipratropium.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 10 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 341 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
341 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists